Skip to main
KYMR
KYMR logo

Kymera Therapeutics (KYMR) Earnings Dates & Reports

Kymera Therapeutics (KYMR) Most Recent Earnings

Report DateAug 11, 2025
Period EndingQ2 2025
Est. EPS-$0.77
Actual EPS-$0.95
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Kymera Therapeutics (KYMR) Earnings per Share (EPS) History

Signup for full access
Browse free

Kymera Therapeutics (KYMR) Latest Earnings

The value each KYMR share was expected to gain vs. the value each share gained.

Kymera Therapeutics (KYMR) reported its most recent earnings on Aug 11, 2025 for Q2 2025, posting earnings per share (EPS) of -$0.95. This exceeded analysts' expectations of -$0.77 by 23.38%, marking a Miss.

For comparison, Kymera Therapeutics reported EPS of -$0.58 in the same quarter last year.

The company is expected to announce its next earnings report on 10/30/2025, with analysts projecting an EPS of -$0.78.

Kymera Therapeutics (KYMR) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2025Oct 30, 2025
-$0.78Next earnings call Oct. 30, 2025
Q2 2025Aug 11, 2025
-$0.77-$0.95+23.38%
Q1 2025May 9, 2025
-$0.91-$0.82-9.89%
Q4 2024Feb 27, 2025
-$0.79-$0.88+11.39%
Q3 2024Oct 31, 2024
-$0.84-$0.82-2.38%
View all

Kymera Therapeutics (KYMR) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Kymera Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Aug 11, 2025
May 9, 2025
Feb 27, 2025
Oct 31, 2024

Kymera Therapeutics (KYMR) Earnings FAQs

Kymera Therapeutics (KYMR) last reported earnings on Aug 11, 2025 for Q2 2025, posting an EPS of -$0.95, which Miss the estimate of -$0.77 by 23.38%.

For Q2 2025, Kymera Therapeutics (KYMR) reported an EPS of -$0.95, missing analysts' estimate of -$0.77 by 23.38%.

For Q2 2025, Kymera Therapeutics (KYMR) Miss expectations with an actual EPS of -$0.95 vs. an estimated EPS of -$0.77.

Following the last earnings report on Aug 11, 2025, Kymera Therapeutics (KYMR)'s stock price moved — from — to —.

The next Kymera Therapeutics (KYMR) earnings call is scheduled for Oct. 30, 2025, where executives will discuss financial results and outlook.

Kymera Therapeutics (KYMR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.